【摘 要】
:
Since 1998 the International Enhanced External Counterpulsation Patient Registry (IEPR) has collected data on baseline characteristics,safety and acute and
【出 处】
:
中国老年学会体外反搏与心血管康复论坛暨第二届国际体外反搏学术交流会
论文部分内容阅读
Since 1998 the International Enhanced External Counterpulsation Patient Registry (IEPR) has collected data on baseline characteristics,safety and acute and long-term outcome of consecutively enrolled patients undergoing EECP for chronic angina.The majority of patients receiving EECP have severe angina,have had previous revascularization,and are no longer suitable for either bypass surgery or percutaneous intervention.Patients show a high rate of comorbid conditions such as diabetes,and congestive heart failure.After a mean treatment time of 34 hours,72% of patients showed reduction in angina.Major adverse coronary events during treatment period are infrequent.On a sample of patients followed to one year,the majority maintain their reduction in angina without occurrence of any major coronary event.
其他文献
EECP is a non-invasive outpatient treatment for cardiovascular disease refractory to medical and/or surgical therapy.It has been cleared by the Food and Dru
The effects of enhanced external counterpulsation (EECP) on Renin-Angiotensin System (RAS) activity in acute MI (AMI) were studies in 18 dogs divided into t
Enhanced external counterpulsation (EECP) is a non-invasive outpatient treatment used for angina pectoris.In patients with intractable angina refractory to
The mechanisms accounting for the salutary benefits of enhanced external counterpulsation (EECP) remain largely unknown.Emerging data now point to three pos
Among 2,486 patients enrolled in the International EECP Patient Registry (IEPR) who underwent EECP therapy for symptomatic coronary artery disease,the media
Enhanced external counterpulsation (EECP) has been shown to reduce angina and to improve objective measures of myocardial ischemia in patients with refracto